Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Ablation Index and VISITAG™ Use for Pulmonary Vein Isolation (PVI) in Patients With Paroxysmal Atrial Fibrillation (PAF)

NCT03062046 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT03062046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03062046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Ablation Index and VISITAG™ Use for Pulmonary Vein Isolation (PVI) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Lead sponsor
Biosense Webster, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 27, 2017
Completion date
March 27, 2019
Enrollment
340 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation